TAT-QFNP12 acetate is a polypeptide that inhibits the binding of NDRG2-PPM1A and reduces the phosphorylation of Smad2/3, leading to a decrease in the production of MMP-9 in astrocytes and mitigating blood-brain barrier disruption following subarachnoid hemorrhage (SAH).
Target:
MMP|||TGF-beta/Smad
* VAT and and shipping costs not included. Errors and price changes excepted
